| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B | 1.44e-22 | 431 | 56 | 22 | GO:0004984 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR3A2 GABRP OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 TMEM63B OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 HTR3B OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B GABRA5 | 2.93e-16 | 1353 | 56 | 26 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B | 6.50e-16 | 884 | 56 | 22 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRP AQP11 TMEM63B ABCB11 SLCO4A1 SV2C CACNA1I SLC35E4 HTR3B PKD1L2 SLC16A7 UNC80 RYR1 RYR2 GABRA5 | 5.62e-07 | 1180 | 56 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GABRP AQP11 TMEM63B ABCB11 SLCO4A1 SV2C CACNA1I SLC35E4 HTR3B PKD1L2 SLC16A7 UNC80 RYR1 RYR2 GABRA5 | 1.71e-06 | 1289 | 56 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | channel activity | GABRP AQP11 TMEM63B CACNA1I HTR3B PKD1L2 UNC80 RYR1 RYR2 GABRA5 | 1.74e-06 | 525 | 56 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRP AQP11 TMEM63B CACNA1I HTR3B PKD1L2 UNC80 RYR1 RYR2 GABRA5 | 1.77e-06 | 526 | 56 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.81e-06 | 459 | 56 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.64e-05 | 193 | 56 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.84e-05 | 197 | 56 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.95e-05 | 334 | 56 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 4.62e-05 | 4 | 56 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.67e-05 | 343 | 56 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.15e-04 | 6 | 56 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 3.33e-04 | 793 | 56 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.71e-04 | 129 | 56 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.41e-04 | 140 | 56 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 8.07e-04 | 65 | 56 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 8.07e-04 | 65 | 56 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 8.50e-04 | 151 | 56 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.00e-03 | 70 | 56 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.15e-03 | 18 | 56 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.15e-03 | 18 | 56 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.18e-03 | 758 | 56 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.28e-03 | 19 | 56 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.32e-03 | 77 | 56 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.72e-03 | 22 | 56 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.46e-03 | 664 | 56 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 2.79e-03 | 28 | 56 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.79e-03 | 100 | 56 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.41e-03 | 31 | 56 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.86e-03 | 33 | 56 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 4.83e-03 | 37 | 56 | 2 | GO:0000175 | |
| GeneOntologyMolecularFunction | odorant binding | 5.45e-03 | 127 | 56 | 3 | GO:0005549 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 5.63e-03 | 40 | 56 | 2 | GO:0016896 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 6.19e-03 | 42 | 56 | 2 | GO:0015144 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 7.08e-03 | 45 | 56 | 2 | GO:0004532 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 7.39e-03 | 46 | 56 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 8.68e-03 | 50 | 56 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.12e-02 | 57 | 56 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.23e-02 | 60 | 56 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 1.27e-02 | 61 | 56 | 2 | GO:0008408 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.31e-02 | 62 | 56 | 2 | GO:0016796 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B | 4.69e-23 | 432 | 55 | 22 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B RYR2 | 1.12e-22 | 524 | 55 | 23 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B | 2.34e-22 | 465 | 55 | 22 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 NAIP OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 PKD1L2 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B RYR2 | 3.06e-22 | 722 | 55 | 25 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B | 5.85e-22 | 485 | 55 | 22 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B | 7.91e-21 | 547 | 55 | 22 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B | 3.01e-20 | 582 | 55 | 22 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 TMEM63B OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B | 8.74e-16 | 1072 | 55 | 23 | GO:0007600 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR3A2 OR51E1 OR4M2 ADCY4 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 OR4M2B | 2.37e-13 | 1395 | 55 | 23 | GO:0007186 |
| GeneOntologyBiologicalProcess | positive regulation of response to food | 1.45e-04 | 7 | 55 | 2 | GO:0032097 | |
| GeneOntologyBiologicalProcess | positive regulation of appetite | 1.45e-04 | 7 | 55 | 2 | GO:0032100 | |
| GeneOntologyBiologicalProcess | positive regulation of response to nutrient levels | 1.93e-04 | 8 | 55 | 2 | GO:0032109 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRP DPP10 AQP11 TMEM63B SLCO4A1 CACNA1I HTR3B PKD1L2 UNC80 RYR1 RYR2 GABRA5 | 2.19e-04 | 1374 | 55 | 12 | GO:0006811 |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 3.78e-04 | 11 | 55 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 6.22e-04 | 14 | 55 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRP DPP10 TMEM63B CACNA1I HTR3B PKD1L2 UNC80 RYR1 RYR2 GABRA5 | 6.48e-04 | 1115 | 55 | 10 | GO:0034220 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 7.07e-06 | 378 | 56 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | cation channel complex | 3.84e-05 | 235 | 56 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 7.19e-05 | 523 | 56 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 1.02e-04 | 550 | 56 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 3.13e-04 | 10 | 56 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | calcium channel complex | 9.92e-04 | 73 | 56 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.17e-03 | 19 | 56 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.43e-03 | 21 | 56 | 2 | GO:1902710 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | AQP11 CH25H TMEM214 UNC93B1 PIGV OR7A10 OR6K6 ALG1 RYR1 RYR2 | 2.08e-03 | 1293 | 56 | 10 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | AQP11 CH25H TMEM214 UNC93B1 PIGV OR7A10 OR6K6 ALG1 RYR1 RYR2 | 2.15e-03 | 1299 | 56 | 10 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | AQP11 CH25H TMEM214 UNC93B1 PIGV OR7A10 OR6K6 ALG1 RYR1 RYR2 | 2.51e-03 | 1327 | 56 | 10 | GO:0042175 |
| GeneOntologyCellularComponent | sodium channel complex | 2.73e-03 | 29 | 56 | 2 | GO:0034706 | |
| Domain | Olfact_rcpt | OR3A2 OR51E1 OR4M2 OR4S2 OR1Q1 OR10W1 OR4M1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 | 9.86e-18 | 393 | 52 | 18 | IPR000725 |
| Domain | GPCR_Rhodpsn_7TM | OR3A2 OR51E1 OR4M2 OR4S2 OR1Q1 OR10W1 OR4M1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 | 1.05e-13 | 670 | 52 | 18 | IPR017452 |
| Domain | 7tm_1 | OR3A2 OR51E1 OR4M2 OR4S2 OR1Q1 OR10W1 OR4M1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 | 1.26e-13 | 677 | 52 | 18 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR3A2 OR51E1 OR4M2 OR4S2 OR1Q1 OR10W1 OR4M1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 | 1.54e-13 | 685 | 52 | 18 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR3A2 OR51E1 OR4M2 OR4S2 OR1Q1 OR10W1 OR4M1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 | 1.78e-13 | 691 | 52 | 18 | PS50262 |
| Domain | GPCR_Rhodpsn | OR3A2 OR51E1 OR4M2 OR4S2 OR1Q1 OR10W1 OR4M1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 | 1.83e-13 | 692 | 52 | 18 | IPR000276 |
| Domain | RyR | 2.28e-05 | 3 | 52 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 2.28e-05 | 3 | 52 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 2.28e-05 | 3 | 52 | 2 | PF06459 | |
| Domain | Ryanrecept_TM4-6 | 2.28e-05 | 3 | 52 | 2 | IPR009460 | |
| Domain | Ryan_recept | 2.28e-05 | 3 | 52 | 2 | IPR013333 | |
| Domain | RIH_assoc | 1.13e-04 | 6 | 52 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.13e-04 | 6 | 52 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 1.13e-04 | 6 | 52 | 2 | PF01365 | |
| Domain | RIH_dom | 1.13e-04 | 6 | 52 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.13e-04 | 6 | 52 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.13e-04 | 6 | 52 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 1.13e-04 | 6 | 52 | 2 | PF08709 | |
| Domain | - | 1.13e-04 | 6 | 52 | 2 | 1.25.10.30 | |
| Domain | Neur_chan_memb | 2.84e-04 | 46 | 52 | 3 | PF02932 | |
| Domain | Neur_chan_LBD | 3.03e-04 | 47 | 52 | 3 | PF02931 | |
| Domain | Neur_channel | 3.03e-04 | 47 | 52 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 3.03e-04 | 47 | 52 | 3 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 3.03e-04 | 47 | 52 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 3.03e-04 | 47 | 52 | 3 | IPR006029 | |
| Domain | - | 3.03e-04 | 47 | 52 | 3 | 2.70.170.10 | |
| Domain | MIR | 3.37e-04 | 10 | 52 | 2 | PS50919 | |
| Domain | MIR | 3.37e-04 | 10 | 52 | 2 | PF02815 | |
| Domain | MIR | 3.37e-04 | 10 | 52 | 2 | SM00472 | |
| Domain | MIR_motif | 3.37e-04 | 10 | 52 | 2 | IPR016093 | |
| Domain | GABAA/Glycine_rcpt | 1.85e-03 | 23 | 52 | 2 | IPR006028 | |
| Domain | MFS | 3.38e-03 | 108 | 52 | 3 | PS50850 | |
| Domain | Ion_trans_dom | 3.94e-03 | 114 | 52 | 3 | IPR005821 | |
| Domain | Ion_trans | 3.94e-03 | 114 | 52 | 3 | PF00520 | |
| Domain | EF-hand_8 | 4.03e-03 | 34 | 52 | 2 | PF13833 | |
| Domain | MFS_dom | 6.18e-03 | 134 | 52 | 3 | IPR020846 | |
| Domain | Neurotransmitter_ion_chnl_CS | 6.97e-03 | 45 | 52 | 2 | IPR018000 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 | 2.93e-20 | 417 | 47 | 21 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR52E1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 | 1.66e-16 | 636 | 47 | 21 | M41834 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR3A2 OR51E1 OR4M2 OR4S2 OR1Q1 OR4M1 OR4C46 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 | 2.84e-15 | 389 | 47 | 17 | M14091 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 5.87e-04 | 11 | 47 | 2 | M47958 | |
| Pubmed | OR3A2 OR51E1 OR4M2 OR4A8 OR4S2 OR4Q2 OR1Q1 OR10W1 OR4M1 OR56A3 OR10K2 OR3A3 OR2J3 OR4D11 OR52M1 OR4X1 OR7A10 OR52B6 OR6K6 | 8.06e-21 | 541 | 56 | 19 | 14983052 | |
| Pubmed | OR51E1 OR4M2 OR4A8 OR4S2 OR1Q1 OR10W1 OR4M1 OR4C46 OR56A3 OR10K2 OR2J3 OR4D11 OR52M1 OR7A10 OR6K6 | 6.74e-18 | 343 | 56 | 15 | 32295537 | |
| Pubmed | OR51E1 OR4M2 OR4A8 OR4S2 OR1Q1 OR10W1 OR4M1 OR4C46 OR56A3 OR10K2 OR2J3 OR4D11 OR52M1 OR7A10 OR6K6 | 7.68e-18 | 346 | 56 | 15 | 14611657 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR51E1 OR4M2 OR4A8 OR4S2 OR1Q1 OR10W1 OR4M1 OR4C46 OR56A3 OR10K2 OR2J3 OR4D11 OR52M1 OR7A10 | 2.23e-16 | 340 | 56 | 14 | 11875048 |
| Pubmed | OR51E1 OR4M2 OR4A8 OR4S2 OR1Q1 OR10W1 OR4M1 OR4C46 OR56A3 OR10K2 OR2J3 OR4D11 OR52M1 OR7A10 | 2.23e-16 | 340 | 56 | 14 | 11802173 | |
| Pubmed | Population differences in the human functional olfactory repertoire. | 1.97e-09 | 11 | 56 | 4 | 12644552 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 6.36e-08 | 219 | 56 | 7 | 12213199 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 30542613 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 2.55e-06 | 2 | 56 | 2 | 11673493 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11673462 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17259277 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 2.55e-06 | 2 | 56 | 2 | 25370123 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 2.55e-06 | 2 | 56 | 2 | 15033925 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 2.55e-06 | 2 | 56 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 2.55e-06 | 2 | 56 | 2 | 26009179 | |
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 2.55e-06 | 2 | 56 | 2 | 18618700 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 32899693 | ||
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 6.38e-06 | 74 | 56 | 4 | 15081110 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 23278119 | ||
| Pubmed | The Asprosin-OLFR734 hormonal signaling axis modulates male fertility. | 7.63e-06 | 3 | 56 | 2 | 31798959 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 9242641 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 18403125 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 22948152 | ||
| Pubmed | Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. | 7.63e-06 | 3 | 56 | 2 | 23454728 | |
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 7.63e-06 | 3 | 56 | 2 | 10788707 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 18434746 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 7.63e-06 | 3 | 56 | 2 | 7621815 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 7.63e-06 | 3 | 56 | 2 | 9204703 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 18643873 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 11159936 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 7876312 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 21881589 | ||
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 7.63e-06 | 3 | 56 | 2 | 9986730 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 24123915 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 32337066 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 7.63e-06 | 3 | 56 | 2 | 10473538 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 7959768 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 7.63e-06 | 3 | 56 | 2 | 12213830 | |
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 7.63e-06 | 3 | 56 | 2 | 4600883 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 7635066 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 9384575 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 18206662 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 22504960 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 9607712 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 27226555 | ||
| Pubmed | OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin. | 1.52e-05 | 4 | 56 | 2 | 31230984 | |
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 19120137 | ||
| Pubmed | FKBP binding characteristics of cardiac microsomes from diverse vertebrates. | 1.52e-05 | 4 | 56 | 2 | 11237759 | |
| Pubmed | Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release. | 1.52e-05 | 4 | 56 | 2 | 23992453 | |
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 23482488 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.52e-05 | 4 | 56 | 2 | 23413940 | |
| Pubmed | Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. | 2.54e-05 | 5 | 56 | 2 | 22939628 | |
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 2.54e-05 | 5 | 56 | 2 | 9124414 | |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 2.54e-05 | 5 | 56 | 2 | 19011160 | |
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 23918386 | ||
| Pubmed | 3.20e-05 | 38 | 56 | 3 | 22908908 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.20e-05 | 38 | 56 | 3 | 30786075 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 19549818 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 19009018 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 3.80e-05 | 6 | 56 | 2 | 26025922 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 23463619 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 3.80e-05 | 6 | 56 | 2 | 16844763 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 3.80e-05 | 6 | 56 | 2 | 14592808 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 3.80e-05 | 6 | 56 | 2 | 25966694 | |
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 12732197 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 11860456 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 20962236 | ||
| Pubmed | 5.71e-05 | 46 | 56 | 3 | 32126975 | ||
| Pubmed | Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. | 7.09e-05 | 8 | 56 | 2 | 18185516 | |
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 7.09e-05 | 8 | 56 | 2 | 19033399 | |
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 12730696 | ||
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 18434328 | ||
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 8004088 | ||
| Pubmed | 1.66e-04 | 12 | 56 | 2 | 19095005 | ||
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 2.29e-04 | 14 | 56 | 2 | 28724790 | |
| Pubmed | Sequence, structure, and evolution of a complete human olfactory receptor gene cluster. | 3.01e-04 | 16 | 56 | 2 | 10673334 | |
| Pubmed | 3.83e-04 | 18 | 56 | 2 | 19078961 | ||
| Pubmed | Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease. | 3.83e-04 | 18 | 56 | 2 | 24058526 | |
| Pubmed | 5.24e-04 | 21 | 56 | 2 | 25708312 | ||
| Pubmed | Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels. | 5.24e-04 | 21 | 56 | 2 | 23747249 | |
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 5.76e-04 | 22 | 56 | 2 | 26494785 | |
| Pubmed | Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species. | 6.87e-04 | 24 | 56 | 2 | 9119360 | |
| Pubmed | Distribution of olfactory receptor genes in the human genome. | 9.37e-04 | 28 | 56 | 2 | 9500546 | |
| Pubmed | 1.15e-03 | 31 | 56 | 2 | 19736351 | ||
| Pubmed | 1.30e-03 | 33 | 56 | 2 | 17350283 | ||
| Pubmed | A probabilistic classifier for olfactory receptor pseudogenes. | 1.46e-03 | 35 | 56 | 2 | 16939646 | |
| Cytoband | 11p15.4 | 4.76e-06 | 200 | 56 | 5 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q11 | 1.64e-05 | 40 | 56 | 3 | chr11q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 6.27e-04 | 564 | 56 | 5 | chr11p15 | |
| Cytoband | 11p11.12 | 1.22e-03 | 42 | 56 | 2 | 11p11.12 | |
| Cytoband | 1q23.1 | 1.46e-03 | 46 | 56 | 2 | 1q23.1 | |
| GeneFamily | Olfactory receptors, family 4 | 9.32e-10 | 129 | 45 | 8 | 151 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.81e-05 | 3 | 45 | 2 | 287 | |
| GeneFamily | Olfactory receptors, family 3 | 9.03e-05 | 6 | 45 | 2 | 150 | |
| GeneFamily | Olfactory receptors, family 52 | 2.45e-04 | 49 | 45 | 3 | 165 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.01e-03 | 19 | 45 | 2 | 563 | |
| GeneFamily | Olfactory receptors, family 10 | 1.17e-02 | 66 | 45 | 2 | 157 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.46e-08 | 184 | 54 | 6 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.24e-06 | 188 | 54 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.41e-06 | 190 | 54 | 5 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.87e-06 | 195 | 54 | 5 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.27e-06 | 199 | 54 | 5 | e2d5c5cab102e67b0131b02392d81adaedc15965 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.30e-05 | 150 | 54 | 4 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.14e-05 | 159 | 54 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.25e-05 | 169 | 54 | 4 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.25e-05 | 169 | 54 | 4 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.42e-05 | 178 | 54 | 4 | ccd37575b60102f5e647c01546e8ff8fec638bd7 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.42e-05 | 178 | 54 | 4 | 87b04753650e45f12299c8456fb980d6c0d5961c | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.42e-05 | 178 | 54 | 4 | ebfae386a518ea33911ba3ff40464c94d18ef695 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.56e-05 | 179 | 54 | 4 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.85e-05 | 181 | 54 | 4 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.61e-05 | 186 | 54 | 4 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.77e-05 | 187 | 54 | 4 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Endothelial-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.77e-05 | 187 | 54 | 4 | fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61 | |
| ToppCell | Endothelial-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 8.26e-05 | 190 | 54 | 4 | 6e83fa0eb8cabe0ffb35375f16e6bf3755ec4977 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 8.60e-05 | 192 | 54 | 4 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 8.78e-05 | 193 | 54 | 4 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 8.95e-05 | 194 | 54 | 4 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-05 | 194 | 54 | 4 | e8102c8811333f04de7280b7d9b6b85cebb815ac | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-05 | 194 | 54 | 4 | 4b0d63babb8a46ff45731d5f82b29ccaf6c9402d | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 9.13e-05 | 195 | 54 | 4 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.32e-05 | 196 | 54 | 4 | 915e4a7422058be246b54760df31e8a607310625 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 9.50e-05 | 197 | 54 | 4 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.50e-05 | 197 | 54 | 4 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 9.50e-05 | 197 | 54 | 4 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1_high|Mild / Condition, Lineage, Cell class and cell subclass | 9.69e-05 | 198 | 54 | 4 | 17aab4dc3b2cd6eb7dda77dd51bdc20490fcfe19 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.69e-05 | 198 | 54 | 4 | 531b0f88c95f813e3914c96749f591e80ca321d0 | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-05 | 199 | 54 | 4 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-05 | 199 | 54 | 4 | 995d710d7302272e7951a5a5d766d1039089ee2b | |
| ToppCell | severe_influenza-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 9.88e-05 | 199 | 54 | 4 | b8adbd6ff5e5602259118a69fd7c77e8348a27e4 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-05 | 199 | 54 | 4 | e9c47f565a0a7737ecff68569d668aeb707ae5a6 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 200 | 54 | 4 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 200 | 54 | 4 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.61e-04 | 133 | 54 | 3 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | IIH-CD4-CD8_2|IIH / Condition, Cell_class and T cell subcluster | 6.12e-04 | 137 | 54 | 3 | 5614a086f5f698e0965f3c7699cffefec5c3b87e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 6.38e-04 | 139 | 54 | 3 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-04 | 143 | 54 | 3 | 4d11d53330a9197275a8851e1bbf55a113715a09 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-04 | 143 | 54 | 3 | 8b9f4d87d5faac7752c83e1992491fc5550600f8 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.07e-04 | 144 | 54 | 3 | 8bd042f12186f36bc5aabf6a0232270a448f4b58 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-04 | 145 | 54 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 7.65e-04 | 148 | 54 | 3 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.95e-04 | 150 | 54 | 3 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.11e-04 | 151 | 54 | 3 | 3b4c57bad61e17a573e6f8dc6b917fba5fd56c43 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-04 | 156 | 54 | 3 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.07e-04 | 157 | 54 | 3 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.41e-04 | 159 | 54 | 3 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 9.58e-04 | 160 | 54 | 3 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor | 9.58e-04 | 160 | 54 | 3 | 0cfe130606af433b2aa90e0a20b6c44659dd6fd4 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.93e-04 | 162 | 54 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-03 | 163 | 54 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.01e-03 | 163 | 54 | 3 | f21951e63188eb0c04675a8f81a0da495c26c007 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-03 | 164 | 54 | 3 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-03 | 164 | 54 | 3 | cfe07a1ebed8aecb08d0476db71fe314998d54aa | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-03 | 164 | 54 | 3 | 6d331e74efecb4733d87653f86cd67247be05025 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-03 | 165 | 54 | 3 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-03 | 166 | 54 | 3 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.07e-03 | 166 | 54 | 3 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 1.10e-03 | 168 | 54 | 3 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 169 | 54 | 3 | a24d12199b1a6d9cb243b3a68f4109d3a30b2dcb | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 169 | 54 | 3 | 573f85075d83a4baba41c3e24dc4d9831823a5e5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-03 | 169 | 54 | 3 | 0867528101767fc65e93b3561480bf830c50368d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 170 | 54 | 3 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 170 | 54 | 3 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_SCN7A|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-03 | 170 | 54 | 3 | a0047551619547971d55165156f61f090948f902 | |
| ToppCell | droplet-Fat-Gat-18m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 170 | 54 | 3 | 5185187ecf26b4c9eaa0c01ad52697ab8d075cc7 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.16e-03 | 171 | 54 | 3 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-03 | 171 | 54 | 3 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-03 | 171 | 54 | 3 | c54dcad75fc378da1943009d7dd872b39ea337c0 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-03 | 171 | 54 | 3 | 8bed33f61f7d12a1ac4fba33f730d839f5ee7bef | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-03 | 172 | 54 | 3 | fc092a0631555d79e00ef9890cbd806e15bca2d4 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-03 | 172 | 54 | 3 | 745725bd10c82017d678463b8fef0d2dcf09a8fd | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-03 | 173 | 54 | 3 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-03 | 173 | 54 | 3 | cc2e489b91562a0c6fe863e2f796f4a7d2ca27dd | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-03 | 173 | 54 | 3 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-03 | 173 | 54 | 3 | 9ba55e21d1037ec3150d77895e52f0b051df65da | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-03 | 174 | 54 | 3 | 18ab52d8bbca0507fee220e0c4fc765fc47dda34 | |
| ToppCell | facs-Kidney-nan-18m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 175 | 54 | 3 | cec941edec6849f2fb602c08fd1eed6d0345f934 | |
| ToppCell | facs-Kidney-nan-18m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 175 | 54 | 3 | 2cb0d07a47bc645cfa690bb853e11d657af19ede | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-03 | 175 | 54 | 3 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-03 | 175 | 54 | 3 | ca0d3e3a0a271cccdd3881b055fecb626712478d | |
| ToppCell | facs-Kidney-nan-18m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 175 | 54 | 3 | 24d58e2f6d36124bde0f2c6f5357b9161bc5f476 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-SMG_basal_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.26e-03 | 176 | 54 | 3 | 045b12c90f7dd49a9778dadcdf8f18125b380531 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 1.26e-03 | 176 | 54 | 3 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.30e-03 | 178 | 54 | 3 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-03 | 178 | 54 | 3 | e1e96a0e3ff718ebf676a982bc63e8ced6984059 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-basal_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.30e-03 | 178 | 54 | 3 | 03f22485074b3cbf9a6ad4d543c5bbfa826dc741 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-03 | 178 | 54 | 3 | 363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.32e-03 | 179 | 54 | 3 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-03 | 179 | 54 | 3 | 40c65e8623547aeb80f9cd2366e29072467ce069 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-03 | 179 | 54 | 3 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-03 | 180 | 54 | 3 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | Endothelial-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.34e-03 | 180 | 54 | 3 | 4c3376169770ee9f9283daae44c17f35e46bfd19 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-03 | 180 | 54 | 3 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-03 | 180 | 54 | 3 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-03 | 180 | 54 | 3 | 6f8fa9fa91cd25b92584972bb34d90c483222f52 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.37e-03 | 181 | 54 | 3 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.37e-03 | 181 | 54 | 3 | 9b2d207dc9fc2228a1555ed360286bb7c2d988ff | |
| Computational | Ion channels. | 4.71e-06 | 70 | 18 | 4 | MODULE_316 | |
| Computational | Ion channels. | 1.12e-05 | 27 | 18 | 3 | MODULE_214 | |
| Computational | Neurotransmitter (GABA) receptor. | 2.75e-04 | 15 | 18 | 2 | MODULE_215 | |
| Computational | Neighborhood of FOS | 2.09e-03 | 41 | 18 | 2 | GNF2_FOS | |
| Drug | baclofen | 4.24e-06 | 191 | 51 | 6 | CID000002284 | |
| Drug | halothane | 6.11e-06 | 314 | 51 | 7 | CID000003562 | |
| Drug | SK&F 82958 | 1.00e-05 | 19 | 51 | 3 | ctd:C071262 | |
| Drug | EBOB | 1.18e-05 | 20 | 51 | 3 | CID000115223 | |
| Drug | 2-hydroxyheptanoic acid | 1.47e-05 | 3 | 51 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.47e-05 | 3 | 51 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 1.47e-05 | 3 | 51 | 2 | CID000127713 | |
| Drug | 2-hydroxycarbazole | 1.47e-05 | 3 | 51 | 2 | CID000093551 | |
| Drug | aminodantrolene | 1.47e-05 | 3 | 51 | 2 | CID009570289 | |
| Drug | cis-diammineplatinum(II | 1.47e-05 | 3 | 51 | 2 | CID000159790 | |
| Drug | nimodipine | 1.81e-05 | 145 | 51 | 5 | CID000004497 | |
| Drug | procaine | 2.35e-05 | 153 | 51 | 5 | CID000004914 | |
| Drug | lidocaine | 2.91e-05 | 160 | 51 | 5 | CID000003676 | |
| Drug | SC 38249 | 2.94e-05 | 4 | 51 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 2.94e-05 | 4 | 51 | 2 | CID000035682 | |
| Drug | PCB74 | 2.94e-05 | 4 | 51 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 2.94e-05 | 4 | 51 | 2 | CID006444275 | |
| Drug | etazolate | 3.71e-05 | 29 | 51 | 3 | CID000003277 | |
| Drug | gabapentin | 3.78e-05 | 169 | 51 | 5 | CID000003446 | |
| Drug | 2,4-xylidinothiazoline | 4.12e-05 | 30 | 51 | 3 | CID000099296 | |
| Drug | riluzole | 4.35e-05 | 174 | 51 | 5 | CID000005070 | |
| Drug | A 68930 | 4.90e-05 | 5 | 51 | 2 | ctd:C065380 | |
| Drug | CNS 1145 | 5.51e-05 | 33 | 51 | 3 | CID000190902 | |
| Drug | IHC-64 | 5.51e-05 | 33 | 51 | 3 | CID000162753 | |
| Drug | AC1O528X | 7.34e-05 | 6 | 51 | 2 | CID006475857 | |
| Drug | NSC114784 | 7.34e-05 | 6 | 51 | 2 | CID000419425 | |
| Drug | MBED | 7.34e-05 | 6 | 51 | 2 | CID000129958 | |
| Drug | chloro-m-cresol | 7.34e-05 | 6 | 51 | 2 | CID000012008 | |
| Drug | secobarbital | 7.80e-05 | 37 | 51 | 3 | CID000005193 | |
| Drug | Azumoleno | 1.03e-04 | 7 | 51 | 2 | CID000056259 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.03e-04 | 7 | 51 | 2 | CID009547999 | |
| Drug | Br2BAPTA | 1.03e-04 | 7 | 51 | 2 | CID003081001 | |
| Drug | barbital | 1.14e-04 | 42 | 51 | 3 | CID000002294 | |
| Drug | thiopental | 1.16e-04 | 112 | 51 | 4 | CID003000715 | |
| Drug | thymol | 1.50e-04 | 46 | 51 | 3 | CID000006989 | |
| Drug | PCB 95 | 2.19e-04 | 10 | 51 | 2 | CID000038012 | |
| Drug | lanthanum | 2.45e-04 | 136 | 51 | 4 | CID000023926 | |
| Drug | Etomidate | 2.67e-04 | 11 | 51 | 2 | ctd:D005045 | |
| Drug | R 478 | 2.67e-04 | 11 | 51 | 2 | CID000084223 | |
| Drug | Bu-1014 | 2.67e-04 | 11 | 51 | 2 | CID015942721 | |
| Drug | fosazepam | 2.67e-04 | 11 | 51 | 2 | CID000037114 | |
| Drug | 2,3,6,2',3',6'-hexachlorobiphenyl | 2.67e-04 | 11 | 51 | 2 | ctd:C010498 | |
| Drug | Zapizolam | 2.67e-04 | 11 | 51 | 2 | CID000068832 | |
| Drug | C19H18ClN3O | 2.67e-04 | 11 | 51 | 2 | CID000027452 | |
| Drug | 8-amino-cADPR | 2.67e-04 | 11 | 51 | 2 | CID003081323 | |
| Drug | flutoprazepam | 2.67e-04 | 11 | 51 | 2 | CID000003400 | |
| Drug | Reclazepam | 2.67e-04 | 11 | 51 | 2 | CID003052777 | |
| Drug | iclazepam | 2.67e-04 | 11 | 51 | 2 | CID000068777 | |
| Drug | Arfendazam | 2.67e-04 | 11 | 51 | 2 | CID000065803 | |
| Drug | menitrazepam | 2.67e-04 | 11 | 51 | 2 | CID000189875 | |
| Drug | PCB 66 | 2.67e-04 | 11 | 51 | 2 | CID000036185 | |
| Drug | Serin hydrazid | 2.67e-04 | 11 | 51 | 2 | CID000041637 | |
| Drug | sulazepam | 2.67e-04 | 11 | 51 | 2 | CID000017931 | |
| Drug | tectoridin | 2.67e-04 | 11 | 51 | 2 | CID005281810 | |
| Drug | elfazepam | 2.67e-04 | 11 | 51 | 2 | CID000065445 | |
| Drug | camazepam | 2.67e-04 | 11 | 51 | 2 | CID000037367 | |
| Drug | uldazepam | 2.67e-04 | 11 | 51 | 2 | CID000034274 | |
| Drug | gidazepam | 2.67e-04 | 11 | 51 | 2 | CID000121919 | |
| Drug | triflubazam | 2.67e-04 | 11 | 51 | 2 | CID000031157 | |
| Drug | fletazepam | 2.67e-04 | 11 | 51 | 2 | CID000036834 | |
| Drug | Cinildipine | 2.70e-04 | 56 | 51 | 3 | CID000002752 | |
| Drug | SB-205384 | 3.20e-04 | 12 | 51 | 2 | CID000197690 | |
| Drug | U-93631 | 3.20e-04 | 12 | 51 | 2 | CID000197626 | |
| Drug | haloxazolam | 3.20e-04 | 12 | 51 | 2 | CID000003563 | |
| Drug | pivoxazepam | 3.20e-04 | 12 | 51 | 2 | CID000068722 | |
| Drug | Ryanodine | 3.20e-04 | 12 | 51 | 2 | ctd:D012433 | |
| Drug | razobazam | 3.20e-04 | 12 | 51 | 2 | CID000071228 | |
| Drug | doxefazepam | 3.20e-04 | 12 | 51 | 2 | CID000038668 | |
| Drug | 5 beta-pregnanediol | 3.31e-04 | 60 | 51 | 3 | CID000012547 | |
| Drug | nilvadipine | 3.31e-04 | 60 | 51 | 3 | CID000004494 | |
| Drug | IAA-94 | 3.48e-04 | 61 | 51 | 3 | CID000003667 | |
| Drug | Bay K 8644 | 3.56e-04 | 150 | 51 | 4 | CID000002303 | |
| Drug | lead compounds | 3.56e-04 | 150 | 51 | 4 | CID000073212 | |
| Drug | MW 1 | 3.65e-04 | 151 | 51 | 4 | CID000073965 | |
| Drug | naphthalene-diisocyanate | 3.65e-04 | 62 | 51 | 3 | CID003033874 | |
| Drug | cinolazepam | 3.78e-04 | 13 | 51 | 2 | CID003033621 | |
| Drug | AC1MVFYM | 3.78e-04 | 13 | 51 | 2 | CID003707225 | |
| Drug | nerisopam | 3.78e-04 | 13 | 51 | 2 | CID000065875 | |
| Drug | flutazolam | 3.78e-04 | 13 | 51 | 2 | CID000003398 | |
| Drug | alpha IMGBL | 3.78e-04 | 13 | 51 | 2 | CID000131516 | |
| Drug | 4-PIOL | 3.78e-04 | 13 | 51 | 2 | CID000125520 | |
| Drug | Ro 11-3128 | 3.78e-04 | 13 | 51 | 2 | CID000093364 | |
| Drug | Mibefradil | 3.78e-04 | 13 | 51 | 2 | ctd:D020748 | |
| Drug | metaclazepam | 3.78e-04 | 13 | 51 | 2 | CID000071272 | |
| Drug | lercanidipine | 3.82e-04 | 63 | 51 | 3 | CID000065866 | |
| Drug | lindane | 3.93e-04 | 154 | 51 | 4 | CID000000727 | |
| Drug | picrotoxinine | 4.19e-04 | 65 | 51 | 3 | CID000004816 | |
| Drug | Me-lex | 4.40e-04 | 14 | 51 | 2 | CID000004177 | |
| Drug | beta-CCt | 4.40e-04 | 14 | 51 | 2 | CID000124514 | |
| Drug | ethyl loflazepate | 4.40e-04 | 14 | 51 | 2 | CID000003299 | |
| Drug | Eudragit RL | 4.40e-04 | 14 | 51 | 2 | CID000104804 | |
| Drug | gallopamil | 4.58e-04 | 67 | 51 | 3 | CID000001234 | |
| Drug | AC1L2AC7 | 5.00e-04 | 69 | 51 | 3 | CID000068733 | |
| Drug | loprazolam | 5.07e-04 | 15 | 51 | 2 | CID003033860 | |
| Drug | SR 95103 | 5.07e-04 | 15 | 51 | 2 | CID000125958 | |
| Drug | FPL 64176 | 5.07e-04 | 15 | 51 | 2 | CID000003423 | |
| Drug | premazepam | 5.07e-04 | 15 | 51 | 2 | CID000072104 | |
| Drug | Gvapspat amide | 5.07e-04 | 15 | 51 | 2 | CID000125015 | |
| Drug | pinazepam | 5.07e-04 | 15 | 51 | 2 | CID000040391 | |
| Drug | fludiazepam | 5.07e-04 | 15 | 51 | 2 | CID000003369 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 7.77e-06 | 3 | 48 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 7.77e-06 | 3 | 48 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 1.13e-05 | 85 | 48 | 4 | C1510586 | |
| Disease | depressive disorder (is_implicated_in) | 3.47e-04 | 17 | 48 | 2 | DOID:1596 (is_implicated_in) | |
| Disease | 1,5 anhydroglucitol measurement | 1.02e-03 | 29 | 48 | 2 | EFO_0008009 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HLKCNFFSDFGSLMT | 1161 | Q13075 | |
| LAMHGFSVTLLGFCN | 56 | Q9BT22 | |
| LIGHFFTICMAFLVL | 301 | O95264 | |
| LMFVGSLCAFLHGIA | 61 | O95342 | |
| TLGFLSCSLFLHMSF | 726 | Q8NFM4 | |
| TLDLILFCFPFHMSQ | 246 | Q5JWR5 | |
| SFSPMNQHFLLFCEG | 481 | Q8N608 | |
| LFFLHFAGASEMFLL | 101 | A0A0X1KG70 | |
| ISFEGCLTQMFFIHL | 91 | Q8NGJ3 | |
| SCMTQIFLFHLLGGA | 96 | Q8NGI4 | |
| LACELGFLFHMLDLS | 556 | Q504Q3 | |
| QMAFFIALGSADCFL | 91 | Q8NGF6 | |
| MINLYGAHTFFLCLE | 251 | Q2M2H8 | |
| HMLELFIAANSGFIC | 191 | A6NHA9 | |
| FDACLLQMFAIHSLS | 96 | Q8TCB6 | |
| CLSQLFFFHLLAGMD | 106 | P47893 | |
| FFFHLLAGMDCFLLT | 111 | P47893 | |
| CLSQLFFFHLLAGMD | 106 | P47888 | |
| FFFHLLAGMDCFLLT | 111 | P47888 | |
| LISFDGCLTQMFFIH | 111 | Q8NGF0 | |
| GCLTQMFFIHFLFIH | 116 | Q8NGF0 | |
| LFFLHFVGASEMFLL | 101 | Q8NGD0 | |
| LFFLHFAGASEMFLL | 101 | Q8NGB6 | |
| QLFFLHFVGAAEMFL | 101 | P0C623 | |
| MLQLFGVHFFGCTEI | 96 | Q8NH73 | |
| SLKGCLTQMFSLHFF | 91 | Q8NH49 | |
| FFSFAIMFNGVCHLL | 316 | O60669 | |
| LLFCISMNLSSHFGF | 16 | P31644 | |
| QTLLMDLGQFLLFCH | 316 | P00451 | |
| LCNHLTFFGSTFLVM | 1311 | Q7Z442 | |
| GASMFFICLFLHIGR | 86 | P00156 | |
| FSILGMHIFGCKFSL | 776 | Q9P0X4 | |
| ALDFMCFLALLFLFS | 46 | Q5T3F8 | |
| ALCFLLLAVAMSFFG | 11 | Q9NZK5 | |
| NNFFFAAHLLDIAMG | 4806 | P21817 | |
| NFFFAAHLLDIAMGF | 4736 | Q92736 | |
| HHILFCLLLFDMEFF | 126 | O95992 | |
| MNYSLHLAFVCLSLF | 1 | O00591 | |
| SVAGCLLQMYFFHSL | 121 | Q8NGW6 | |
| MFSFLFLGCSHSFLL | 101 | Q6IF99 | |
| AMLHTFLIGQLIFCA | 156 | Q15612 | |
| FGTCGAHLMAVSLFF | 241 | O76001 | |
| SFPACMGQLFIEHLF | 91 | P0C604 | |
| LDACLGQMFLIHCFA | 96 | Q8NGK5 | |
| MIFNLADTHLFFNDL | 311 | O00167 | |
| AFLCFLMHARGQRDF | 11 | P55808 | |
| LLICMSVNGFFAFLS | 221 | Q496J9 | |
| MCFFLLFVGLDNFLL | 101 | O76100 | |
| AAGVMLLCHFFTDQF | 11 | Q6UX71 | |
| ALSTCGSHFMLILFF | 241 | Q8NH54 | |
| LFFLCAAAFLQGMTV | 106 | Q96BD0 | |
| NPALALSLHFMCFDE | 216 | Q8NBQ7 | |
| LSLHFMCFDEAFPQF | 221 | Q8NBQ7 | |
| SLNFLFFMLAAVALH | 121 | Q9NUD9 | |
| FFMLAAVALHDLGCL | 126 | Q9NUD9 | |
| SFFHLSFACAQLPMI | 226 | Q9H1C4 | |
| MHLLGFFSVACSLLA | 1 | P49767 | |
| ILFNFLMDFLTNCIG | 826 | Q9C0E2 | |
| NNVVDFLHALLGFCM | 856 | Q8N2C7 | |
| VFMCFFVGNDFLPHL | 336 | Q9H0D6 | |
| GSLELFFDHCLFTML | 191 | Q6NUQ4 | |
| ALTLSGMFLYHNCEF | 316 | Q6ICL7 |